Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil in Solid Organ Transplant Recipients
NCT00677677Phase 3Completed
- Sponsor
- University of Alberta
- Start
- May 2008
- Primary completion
- Apr 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of qHPV vaccine in human papillomavirus infection, sponsored by University of Alberta. Primary endpoint: 2-fold rise in the type-specific HPV titer for at least one of the four serotypes at 7 months. Started May 2008; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00677677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00677677.